Page 44 - Heca News Today

Britain's antitrust regulator said on Monday it was looking into whether the anticipated acquisition by Électricité de France SA of the nuclear steam power business owned by General Electric Co could lead to competition concerns.

Novartis's Kisqali breast cancer drug cut the risk of recurrence in women who were diagnosed at an early stage of the disease in a pivotal trial, providing a confidence boost for the drugmaker's growth prospects.

The Chinese foreign ministry said on Monday that an employee of Japanese firm Astellas Pharma had been detained on suspicion of espionage.

Major Gulf markets opened mixed on Monday, mirroring gains in oil prices as investors pin their hopes on modest interest rate hikes amid governments' efforts to soothe fears over the global banking system.

BioNTech plans to spend up to about 1 billion euros ($1.1 billion) more on research and development and buy back up to $500 million more of its shares this year, drawing on more than 21 billion euros from the now waning commercial success of its COVID-19 vaccine.

Elon Musk's brain implant company Neuralink has approached one of the biggest U.S. neurosurgery centers as a potential clinical trials partner as it prepares to test its devices on humans once regulators allow for it, according to six people familiar with the matter.

High-speed train traffic between France and Belgium was interrupted on Monday, affecting Eurostar, TGV and Thalys, after a train touched an overhead wire used to provide current, Belgian rail management company Infrabel told Reuters.

Three pharmacy benefit management (PBM) companies are being sued in Ohio over allegations of drug price fixing, the Wall Street Journal reported on Monday.

Codiak BioSciences Inc said on Monday it has filed for U.S. bankruptcy protection in the latest blow to the struggling drug developer's ambitions of making a COVID-19 vaccine.

The top animal care official at the U.S. Department of Agriculture who was subpoenaed by a federal grand jury last year as part of a criminal probe into animal researcher breeder Envigo's abuse of beagles is retiring, according to an internal email seen by Reuters on Monday.